InterCure Expands Cookies Partnership to Germany
Ticker: INCR · Form: 6-K · Filed: Aug 28, 2024 · CIK: 1857030
| Field | Detail |
|---|---|
| Company | Intercure Ltd. (INCR) |
| Form Type | 6-K |
| Filed Date | Aug 28, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: international-expansion, partnership, pharmaceutical-cannabis
TL;DR
InterCure taking its weed to Germany via Cookies partnership.
AI Summary
InterCure Ltd. announced on August 28, 2024, the expansion of its strategic partnership with Cookies to Germany. This move aims to introduce InterCure's pharmaceutical cannabis products to the German market, leveraging Cookies' brand recognition and distribution network.
Why It Matters
This expansion signifies InterCure's strategic growth into a key European market, potentially increasing revenue and market share in the pharmaceutical cannabis sector.
Risk Assessment
Risk Level: medium — Expansion into new international markets carries inherent regulatory, operational, and competitive risks.
Key Players & Entities
- InterCure Ltd. (company) — Registrant
- Cookies (company) — Strategic Partner
- Germany (location) — New Market
- Amos Cohen (person) — Chief Financial Officer
- August 28, 2024 (date) — Filing Date and Announcement Date
FAQ
What is the primary purpose of this 6-K filing?
This 6-K filing is to report the expansion of InterCure Ltd.'s strategic partnership with Cookies to Germany, as detailed in the press release dated August 28, 2024.
Who is InterCure Ltd. partnering with for this expansion?
InterCure Ltd. is expanding its strategic partnership with Cookies.
Which new market is InterCure Ltd. entering with this partnership expansion?
InterCure Ltd. is expanding its partnership to Germany.
What is the date of the press release attached to this filing?
The press release attached as Exhibit 99.1 is dated August 28, 2024.
Who signed this report on behalf of InterCure Ltd.?
Amos Cohen, Chief Financial Officer, signed the report on behalf of InterCure Ltd.
Filing Stats: 148 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-08-28 08:40:44
Filing Documents
- form6-k.htm (6-K) — 16KB
- ex99-1.htm (EX-99.1) — 17KB
- ex99-1_001.jpg (GRAPHIC) — 17KB
- 0001493152-24-034122.txt ( ) — 58KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Intercure Ltd. Date: August 28, 2024 By: /s/ Amos Cohen Amos Cohen Chief Financial Officer